Priority Date: 08.05.12 (US 201261644265P)

STANDARDIZED EX VIVO PLATFORMS FOR THE ANTIGEN-SPECIFIC EXPANSION OF CD4+ T CELL POPULATIONS

  • Application ID: EP13788471
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorney

Employment test 1 - 10 employees
Company dna fleischer engels and partner mbb
no operation time available
Headquarter in Bergisch Gladbach
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Fleischer Engels & Partner mbB is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 08.05.2012 - Priority Date (US 201261644265P)
  • 14.11.2013 - Publication A1 (WO2013169922)
  • 18.03.2015 - Publication A1 (EP2847322)

IPC Classification